Loading…
← CockpitCompetitor Analysis › 085620.KS Mirae Asset Life Insurance Co., Ltd.Open in the cockpit ↗

Mirae Asset Life Insurance Co., Ltd.085620.KSCompetitor analysis, valuation and peers

South Korea · KRW·Financials›Life/Health Insurance

Life insurer under Mirae Asset Financial Group, selling life, health and variable/investment-linked insurance products.

Momentum leader 88
Mkt cap
$1.70B
US dollars, full cap
Free float
38%
of shares outstanding
$/day
$1.40M
20-day average traded
P/B
1.06×
price to book
ROE
1.8%
delivered
Implied ROE
5.8%
what the price asks
Next earnings
98 days
24 Feb 2027
Close · KRW₩17,620
1D+5.5%
1W-13.6%
1M+4.3%
3M-15.5%
6M+18.7%
YTD+87.8%
1Y+94.0%
ATR %8.1%
52w lowhigh52.8% off high

What Mirae Asset Life Insurance does

Life insurer under Mirae Asset Financial Group, selling life, health and variable/investment-linked insurance products.

Earns from premiums collected on life and health policies, plus investment income on the money it holds until claims are paid. On variable (investment-linked) policies the customer carries the market result, so the insurer earns fees for managing the fund rather than keeping the gain.

Products and services

  • Life insurance
  • Variable/investment-linked insurance
  • Health insurance

Customers

  • Retail policyholders

Where it sits in the supply chain

  • Insurance
  • Life and health insurance
  • Investment-linked products

What could go right

  • Investment-linked product demand
  • Mirae Asset group distribution synergies

What could go wrong

  • Low interest-rate margin pressure
  • Regulatory capital requirements

Moat: narrow (distribution, brand). Leverages Mirae Asset's broader wealth-management distribution network.

Headquarters: Seoul, South Korea · Employees: 793

Named competitors

Mirae Asset Life Insurance at a glance

Size Mirae Asset Life Insurance (085620.KS) is a South Korea Financials company (Life/Health Insurance) with a market value of $1.70B, the 157th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩17,620 on 18 Nov 2026.

Performance Over six months the shares gained 18.7%, against -4.1% for the median peer and -37.2% for the South Korea market (cap-weighted) — 2nd highest of 17 in its peer set.

Growth Revenue grew 152.1% over the last twelve months (peer median +17.3%); the operating margin is 4.0% (peer median 6.8%).

Valuation It trades at 1.06× book value against a peer median of 1.35× (8th cheapest of 17).

Price implies The share price implies a return on equity of about 5.8%; Mirae Asset Life Insurance delivers 1.8%, so the price asks more than the business earns today.

Next results Next results expected around 24 Feb 2027 (exchange calendar; dates can move).

Relative performance

10015020021 May 202621 Aug 202618 Nov 2026085620.KS 119Peer median 94
Six months, rebased to 100: Mirae Asset Life Insurance against the median of its 16 peers (local-currency closes).

Mirae Asset Life Insurance financials

Reported figures in KRW; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₩5.64T₩2.52T₩2.17T₩2.19T₩4.89T
Revenue growth—+16%-1%-55%—
Net income₩43.0B₩131B₩136B₩101B₩125B
Free cash flow-₩509B-₩247B-₩2.31T-₩2.17T-₩2.63T
Capital expenditure₩41.7B₩79.6B₩15.7B₩11.4B₩17.4B
Total debt₩337B₩616B₩522B₩557B₩1.01T

Quarterly statements and history in the cockpit →

Mirae Asset Life Insurance competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-20%-10%0%+10%NBG6NIVABUPA088350CLOVCANHLIFEBHFPRVA0376STARHEALTH7157ELF5859MFSLCGF2905085620.KS6-month return →1-month return →
Up and to the right = strong over both horizons. Mirae Asset Life Insurance is the large dot.

Fundamentals: return on equity against price-to-book

-100%-50%0%00×2.50×50×7.50×NBG6NIVABUPA088350CLOVCANHLIFEBHF002423PRVASTARHEALTHELFMFSLCGF2905085620.KSReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Mirae Asset Life Insurance is the large dot.

Capital: ROE delivered against the ROE the price implies

-100%-50%0%50%-100%0%NBG6NIVABUPA088350CLOVCANHLIFEMFSLCGF2905085620.KSROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Mirae Asset Life Insurance is the large dot.

Mirae Asset Life Insurance competitors and peer comparison

Head to head with its named competitors (085620.KS vs 088350.KS vs 032830.KS)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Mirae Asset Life Insurance 085620.KS$1.70B+19%+152%2%1.06×5.8%
Hanwha Life 088350.KS$2.09B-33%+20%5%0.23×3.8%
Samsung Life 032830.KS$34.1B-23%+33%4%0.37×5.0%

How Mirae Asset Life Insurance compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Mirae Asset Life Insurance against its 16 peers (data as of 18 Nov 2026)
Measure085620.KSPeer medianRank in peer set
1-month return+4.3%-1.6%3rd highest of 17
6-month return+18.7%-4.1%2nd highest of 17
Return on equity1.8%6.9%2nd lowest of 17
Price / book1.06×1.35×8th cheapest of 17
Trailing P/E52.5×17.0×4th most expensive of 16
ROE the price implies5.8%7.2%4th least demanding of 17
ROE delivered1.8%6.9%2nd lowest of 17

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Mirae Asset Life Insurance 085620.KSSouth Korea$1.70B+19%+152%2%1.06×5.8%1.8%
Nuernberger Beteiligungs NBG6.DEGermany$1.55B+2%-1%5%1.58×6.1%5.1%
Niva Bupa Health Insurance NIVABUPA.NSIndia$1.46B-9%+58%14%3.55×32.5%13.9%
Hanwha Life 088350.KSSouth Korea$2.09B-33%+20%5%0.23×3.8%4.6%
Clover Health Investments CLOVUnited States$2.21B+16%+54%3%5.31×81.1%3.4%
Canara HSBC Life Insurance CANHLIFE.NSIndia$1.29B-8%+17%8%7.36×50.5%8.2%
Brighthouse Financial BHFUnited States$2.42B-33%-9%12%0.48×6.0%12.0%
COFCO Capital 002423.SZChina$3.08B-7%-31%6%0.83×6.1%5.6%
Privia Health PRVAUnited States$3.14B+6%+19%5%3.85×25.7%4.6%
Yunfeng Financial 0376.HKHong Kong$872M-24%+21%7%0.53×7.4%6.7%
Star Health & Allied Insurance STARHEALTH.NSIndia$3.53B+8%+21%12%3.16×47.6%11.7%
Lifenet Insurance 7157.TJapan$652M-28%+11%8%1.11×7.0%7.6%
E-L Financial ELF.TOCanada$4.65B+15%+32%20%0.69×6.5%20.2%
Farglory Life Insurance 5859.TWOTaiwan$614M-1%-48%7%0.22×1.7%7.1%
Max Financial Services MFSL.NSIndia$5.25B-12%+18%3%8.53×87.5%3.3%
Challenger CGF.AXAustralia$5.26B+28%-25%13%1.95×15.5%13.3%
Mercuries & Associates 2905.TWTaiwan$456M+11%-43%-118%0.56×2.7%-117.8%

Questions

Who are Mirae Asset Life Insurance's main competitors?
Named competitors: Hanwha Life (088350.KS), Samsung Life Insurance (032830.KS). The cockpit's measured peer set (industry) also includes Nuernberger Beteiligungs (NBG6.DE), Niva Bupa Health Insurance (NIVABUPA.NS), Hanwha Life (088350.KS), Clover Health Investments (CLOV), Canara HSBC Life Insurance (CANHLIFE.NS), Brighthouse Financial (BHF).
Is Mirae Asset Life Insurance expensive compared with its peers?
On price / book it trades at 1.06× against a peer median of 1.35×, 8th cheapest of 17 in its peer set. The share price implies a return on equity of about 5.8%; Mirae Asset Life Insurance delivers 1.8%, so the price asks more than the business earns today.
How has Mirae Asset Life Insurance stock performed?
Over six months to 18 Nov 2026 the shares returned +18.7% against -4.1% for the median peer; over one year +94.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.